Distress and its correlates in Korean cancer patients: pilot use of the distress thermometer and the problem list

Shim, Eun‐Jung; Shin, Yong-il; Jeon, Hong Jin; Hahm, Bong‐Jin

doi:10.1002/pon.1275

Cited by 159 publications

(160 citation statements)

References 37 publications

Supporting

Mentioning

115

Contrasting

Unclassified

Order By: Relevance

“…and to rate on a 0 -10 scale his/her level of distress (0 ¼ no distress; 10 ¼ extreme distress). The DT has been shown to be a reliable instrument in several studies (Jacobsen et al, 2005;Dolbeault et al, 2008;Shim et al, 2008;Grassi et al, 2009Grassi et al, , 2010. For the aim of the SEPO study the List of Problems accompanying the DT was not used.…”

Section: Methodsmentioning

confidence: 99%

Do spirituality and faith make a difference? Report from the Southern European Psycho-Oncology Study Group

et al. 2010

View full text Add to dashboard Cite

Objective: In the last decade, some attention has been given to spirituality and faith and their role in cancer patients' coping. Few data are available about spirituality among cancer patients in Southern European countries, which have a big tradition of spirituality, namely, the Catholic religion. As part of a more general investigation (Southern European Psycho-Oncology Study -SEPOS), the aim of this study was to examine the effect of spirituality in molding psychosocial implications in Southern European cancer patients.Method: A convenience sample of 323 outpatients with a diagnosis of cancer between 6 to 18 months, a good performance status (Karnofsky Performance Status . 80), and no cognitive deficits or central nervous system (CNS) involvement by disease were approached in university and affiliated cancer centers in Italy, Spain, Portugal, and Switzerland (Italian speaking area). Each patient was evaluated for spirituality (Visual Analog Scale 0-10), psychological morbidity (Hospital Anxiety and Depression Scale-HADS), coping strategies (Mini-Mental Adjustment to Cancer -Mini-MAC) and concerns about illness (Cancer Worries Inventory -CWI).Results. The majority of patients (79.3%) referred to being supported by their spirituality/ faith throughout their illness. Significant differences were found between the spirituality and non-spirituality groups ( p 0.01) in terms of education, coping styles, and psychological morbidity. Spirituality was significantly correlated with fighting spirit (r ¼ 20.27), fatalism (r ¼ 0.50), and avoidance (r ¼ 0.23) coping styles and negatively correlated with education (r ¼ 20.25), depression (r ¼ 20.22) and HAD total (r ¼ 20.17).Significance of results: Spirituality is frequent among Southern European cancer patients with lower education and seems to play some protective role towards psychological morbidity, specifically depression. Further studies should examine this trend in Southern European cancer patients.

show abstract

Section: Methodsmentioning

confidence: 99%

Do spirituality and faith make a difference? Report from the Southern European Psycho-Oncology Study Group

et al. 2010

View full text Add to dashboard Cite

show abstract

“…Estos resultados son congruentes con gran parte de la literatura previa (9)(10)(11)17,18) , que propone el uso de un punto de corte de 4 en el TD como límite ideal para detectar pacientes oncológicos con malestar emocional. Sin embargo, estos pacientes detectados lo serían de acuerdo con la HADS, que es a su vez una prueba de cribado, no siendo una medida pura de los verdaderos positivos.…”

Section: Discussionunclassified

“…El TD ha sido adaptado a distintas lenguas y poblaciones (6)(7)(8)(9)(10)(11)(12)(13)(14)(15) y se ha utilizado para la detección temprana del malestar emocional en pacientes con distintos tipos de cáncer (5,(15)(16)(17)(18) . Se han llevado a cabo estudios de validación utilizando pruebas bien establecidas para la detección de sintomatología ansioso-depresiva como la Escala de Ansiedad y Depresión Hospitalaria (19) o el Inventario Breve de Síntomas (20) , entre otras.…”

Section: Introductionunclassified

“…El primero de estos estudios fue llevado a cabo por Roth et al quienes encontraron una concordancia del 74,4% entre el TD y la HADS utilizando un punto de corte de 5 puntos, en una muestra de 93 pacientes con cáncer de próstata (5) . Sin embargo, no existe acuerdo entre los autores sobre cuál es el punto de corte óptimo que debe utilizarse, que varía en los diferentes estudios (tabla 1), entre 4 (8)(9)(10)(11)17,18,21,22) y 5 puntos (6,12,13,15,(23)(24)(25)(26) . Con el fin de organizar toda la información en este campo, se han llevado a cabo revisiones sistemáticas (27,28) y metaanáli-sis (29,30) para el estudio de la eficacia de los métodos de cribado del malestar emocional en pacientes oncológicos.…”

Section: Introductionunclassified

See 1 more Smart Citation

El termómetro del distrés como prueba de cribado de ansiedad y depresión en pacientes oncológicos recién diagnosticados

et al. 2014

View full text Add to dashboard Cite

ResumenObjetivo: El Termómetro del Distrés (TD) es una de las pruebas de cribado de malestar emocional más utilizadas y estudiadas en pacientes oncológicos. Sin embargo, genera numerosos falsos positivos. Además, aún no ha sido convenientemente estudiado con población española, ni en muestras de pacientes recién diagnosticados. El presente estudio analiza el rendimiento diagnóstico del TD en una muestra española de pacientes oncológicos recién diagnosticados.Método: Se evaluó el rendimiento diagnós-tico del TD en una muestra de 135 pacientes con diagnóstico oncológico empleando como pruebas de referencia la Escala de Ansiedad y Depresión Hospitalaria (HADS) y una entrevista diagnóstica semiestructurada.Resultados: El TD mostró un rendimiento diagnóstico aceptable (Área Bajo la Curva, ABC=0,79) para detectar malestar emocional usando la HADS como referencia. El punto de corte óptimo fue de 4 puntos (Sensibilidad=0,89; Especificidad=0,56). El rendimiento diagnóstico del TD empleando la combinación de la entrevista clínica y la HADS como referencia fue bueno (ABC=0,86). El punto de corte óptimo fue de 6 puntos (Sensibilidad=0,82; Especificidad=0,76). AbstractObjective: The Distress Thermometer (DT) is one of the most used and studied screening tests of psychological distress in cancer patients. However, it includes many false positives. Furthermore, it has not been adequately studied with Spanish populations or with recently diagnosed patients. This research examines the diagnostic performance of the DT with a sample of Spanish recently diagnosed cancer patients.Method: The diagnostic performance of DT was assessed in a sample of 135 recently diagnosed cancer patients using the Hospital Anxiety and Depression Scale (HADS) and a semi-structured diagnostic interview as gold standard.Results: The diagnostic performance of DT was acceptable (AUC=0.79) to detect psychological distress using the HADS as gold standard. The optimal cut-off score was 4 (Sensitivity=0.89; Specificity=0.56). The diagnostic performance of DT using the HADS plus the diagnostic interview as gold standard was good (AUC=0.86).The optimal cut-off score was 6 (sensitivity=0.82; Specificity=0.76).Discussion: The DT is an appropriate screening test to detect anxiety and depressive disorders in recently diagnosed cancer

show abstract

“…the HADS [19], the Hornheide Questionnaire [20,21], the Stress Index RadioOncology (SIRO, [22]), the Distress Thermometer [23,24], the PsychooncologicalBasic Documentation (PO-Bado, [25]), the Brief Symptom Inventory (BSI, [26,27]), the SymptomChecklist-90-R (SCL-90-R, [28,29]) and the GHQ-12.…”

Section: Introductionmentioning

confidence: 99%

Development of a screening tool for the identification of psychooncological treatment need in breast cancer patients

et al. 2009

View full text Add to dashboard Cite

Objective: In breast cancer patients the diagnosis, treatment and aftercare of the physical disease cause a large amount of psychosocial distress, which can have a variety of negative consequences on patients' physical and mental well-being. Although about one-third of the patients show heightened psychosocial distress that may require psychooncological interventions its detection in daily clinical routine is poor and referral to mental health professionals is insufficient. The aim of the study was to develop a short screening tool for the detection of need for psychooncological treatment (POT) in breast cancer patients.Methods: Over a period of six months, 115 breast cancer outpatients attending the Department of Gynaecology at Innsbruck Medical University were consecutively included in the study. Logistic regression analysis and ROC analyses were used to identify the most predictive item set from a set of questionnaires (EORTC-QLQ-C30, HADS and Hornheide Screening Instrument) and other additional questions.Results: Data from 105 breast cancer patients (mean age 58.8, SD 12.3) were available for analysis. A logistic regression equation containing the EORTC-QLQ-C30 scales Emotional Functioning and Role Functioning as well as the yes-no question after psychiatric/ psychological/psychotherapeutic treatment at any point in lifetime showed highest predictive power with regard to need of POT (AUC 5 0.88; CI 95% 0.82-0.95). A pilot study (n 5 20) investigating applicability of a computerized version of this screening tool in oncological routine showed high acceptance and feasibility.Conclusion: The developed PO-screening tool showed high diagnostic accuracy regarding POT needs. The short assessment time and good usability of its computerized version allowed easy implementation in daily oncological routine.

show abstract

Distress and its correlates in Korean cancer patients: pilot use of the distress thermometer and the problem list

Cited by 159 publications

References 37 publications

Do spirituality and faith make a difference? Report from the Southern European Psycho-Oncology Study Group

Do spirituality and faith make a difference? Report from the Southern European Psycho-Oncology Study Group

El termómetro del distrés como prueba de cribado de ansiedad y depresión en pacientes oncológicos recién diagnosticados

Development of a screening tool for the identification of psychooncological treatment need in breast cancer patients

Contact Info

Product

Resources

About